TECX (Tectonic Therapeutic) ROC (Joel Greenblatt) %: -1,713.94% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TECX Tectonic Therapeutic Inc TECX
14 GF Score
Price $33.98
! 3 Warning Signs
View Full Analysis

What is Tectonic Therapeutic ROC (Joel Greenblatt) %?

Tectonic Therapeutic TECX -7.84% 14 ROC (Joel Greenblatt) % is -1,713.94% as of Jun. 2026. GuruFocus rates TECX with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 1,324 Biotechnology companies, Tectonic Therapeutic ranks worse than 76.06% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Tectonic Therapeutic's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -1,713.94%.

The historical rank and industry rank for Tectonic Therapeutic's ROC (Joel Greenblatt) % or its related term are showing as below:

TECX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2226   Med: -508.53   Max: -231.88
Current: -2226

During the past 5 years, Tectonic Therapeutic's highest ROC (Joel Greenblatt) % was -231.88%. The lowest was -2226.00%. And the median was -508.53%.

TECX's ROC (Joel Greenblatt) % is ranked worse than
76.06% of 1324 companies
in the Biotechnology industry
Industry Median: -305.105 vs TECX: -2226.00

Tectonic Therapeutic's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Tectonic Therapeutic  (NAS:TECX) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Tectonic Therapeutic ROC (Joel Greenblatt) % Related Terms


Tectonic Therapeutic ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Tectonic Therapeutic's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tectonic Therapeutic ROC (Joel Greenblatt) % Chart

Tectonic Therapeutic Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
-231.88 -484.95 -508.53 -923.56 -1,854.13

Tectonic Therapeutic Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,886.84 -2,427.31 -2,899.08 -2,494.61 -1,713.94

TECX vs ZVRA, SPRY, RLMD: ROC (Joel Greenblatt) % Comparison

For the Biotechnology subindustry, Tectonic Therapeutic's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tectonic Therapeutic ROC (Joel Greenblatt) % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tectonic Therapeutic's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Tectonic Therapeutic's ROC (Joel Greenblatt) % falls into.


TECX
14GF Score
Tectonic Therapeutic Inc TECX
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tectonic Therapeutic ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 2.997) - (10.062 + 0 + 1.465)
=-8.53

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 4.03) - (6.219 + 0 + 2.57)
=-4.759

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Tectonic Therapeutic for the quarter that ended in Jun. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-88.808/( ( (5.538 + max(-8.53, 0)) + (4.825 + max(-4.759, 0)) )/ 2 )
=-88.808/( ( 5.538 + 4.825 )/ 2 )
=-88.808/5.1815
=-1,713.94 %

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -1,713.94% mean?
Tectonic Therapeutic (TECX) has a ROC (Joel Greenblatt) % of -1,713.94% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Tectonic Therapeutic and its competitors. According to the industry distribution chart, Tectonic Therapeutic ranks #1007 out of 1324 companies in the Biotechnology industry, placing it in the top 76.1%.
Is Tectonic Therapeutic's ROC (Joel Greenblatt) % too high?
Tectonic Therapeutic's current ROC (Joel Greenblatt) % is -1,713.94%. Based on the distribution chart, Tectonic Therapeutic ranks #1007 out of 1324 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Tectonic Therapeutic has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tectonic Therapeutic's ROC (Joel Greenblatt) % compare to ZVRA and SPRY?
According to the Biotechnology industry distribution chart, Tectonic Therapeutic ranks #1007 out of 1324 companies for ROC (Joel Greenblatt) %. This places Tectonic Therapeutic in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Biotechnology company?
A good ROC (Joel Greenblatt) % depends on the Biotechnology industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Tectonic Therapeutic and its competitors. Tectonic Therapeutic's current ROC (Joel Greenblatt) % is -1,713.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tectonic Therapeutic stock overvalued right now?
Tectonic Therapeutic (TECX) has a current ROC (Joel Greenblatt) % of -1,713.94%. The current ROC (Joel Greenblatt) % is -1,713.94%. Tectonic Therapeutic's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Tectonic Therapeutic (TECX), the current ROC (Joel Greenblatt) % is -1,713.94% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tectonic Therapeutic Business Description

Address 490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
14GF Score

Get the complete analysis for TECX

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$33.98
Price